Psychedelic Assisted Therapy

3 units

Psilocybin, MDMA, and LSD have all received a “Breakthrough Therapy” designation from the FDA, with anticipated rescheduling in the near future. Additionally, the prevalence of ketamine-assisted psychotherapy practices and increased access to these medicines overall make it important for social work clinicians to be familiar with Psychedelic-Assisted Therapy (PAT) practices. This course offers an in-depth overview of PAT practices and protocols, including session types, best-practices, safety, and consent. This will include the use of PAT in work with specific diagnostic presentations and in conjunction with other clinical interventions. In addition, this course will examine models of community-based healing and peer-support. This course is designed for students who are planning to use PAT in their clinical practice.